ScholarIQanswers from OpenAlex & ORCID
W. Marston Linehan
ResearcherPublications, citations & collaboration network
W. Marston Linehan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does W. Marston Linehan have?
ScholarIQindexed works
W. Marston Linehan has 469 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does W. Marston Linehan have?
ScholarIQcitation count
W. Marston Linehan has 33,787 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of W. Marston Linehan?
ScholarIQh-index
W. Marston Linehan has an h-index of 77 in OpenAlex.
What is the i10-index of W. Marston Linehan?
ScholarIQi10-index
W. Marston Linehan has an i10-index of 187 in OpenAlex.
What is the ORCID of W. Marston Linehan?
ScholarIQorcid
The ORCID for W. Marston Linehan is on the source record.
What is the OpenAlex record for W. Marston Linehan?
ScholarIQopenalex
The OpenAlex for W. Marston Linehan is on the source record.
What are the most-cited papers on W. Marston Linehan?
ScholarIQmost cited works
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Biagio Ricciuti, Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong, Jianjun Zhang, Michael Tolstorukov, Yvonne Y. Li, Liam F. Spurr, Andrew D. Cherniack, Gonzalo Recondo, Giuseppe Lamberti, Xinan Wang, Deepti Venkatraman, Joao V. Alessi, Victor R. Vaz, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, S. Khosrowjerdi, Subba R. Digumarthy, Hyesun Park, Nuno Vaz, Mizuki Nishino, Lynette M. Sholl, David A. Barbie, Mehmet Altan, John V. Heymach, Ferdinandos Skoulidis, Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer
Justin F. Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo‐Jack, Luc Friboulet, W. Marston Linehan, Harper Hubbeling, Leila Dardaei, Anna F. Farago, Katherine R. Schultz, Lorin A. Ferris, Zofia Piotrowska, James C.H. Hardwick, Donghui Huang, Mari Mino–Kenudson, A. John Iafrate, Aaron N. Hata, Beow Y. Yeap, Alice T. Shaw
Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer
Alexander Drilon, D. Ross Camidge, W. Marston Linehan, Sang‐We Kim, Benjamin Solomon, Rafał Dziadziuszko, Benjamin Besse, Kōichi Goto, Adrianus J. de Langen, Jürgen Wolf, Ki Hyeong Lee, Sanjay Popat, Christoph Springfeld, Misako Nagasaka, Enriqueta Felip, Nong Yang, Vamsidhar Velcheti, Shun Lü, Steven Kao, Christophe Dooms, Matthew Krebs, Wenxiu Yao, Muhammad Shaalan Beg, Xiufeng Hu, Denis Moro‐Sibilot, Parneet Cheema, Shanna Stopatschinskaja, Minal Mehta, Denise Trone, Armin Graber, Gregory E. Sims, Yong Yuan, Byoung Chul Cho